Sea Limited to Report Second Quarter 2022 Results
SINGAPORE--(BUSINESS WIRE)--Sea Limited (NYSE: SE) (“Sea” or the “Company”) plans to announce its second quarter 2022 results before the U.S....
Alex
Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Kioxia Launches Second Generation of High-Performance, Cost-Effective XL-FLASH™ Storage Class Memory Solution
TOKYO--(BUSINESS WIRE)--Kioxia Corporation, the world leader in memory solutions, today announced the launch of the second generation of XL-FLASH™, a...
Finalization of Vifor Pharma acquisition
All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August...
AMTD Digital Inc.: Thank you note to investors and our response to our latest ADS price performance
NEW YORK & SINGAPORE & HONG KONG--(BUSINESS WIRE)--AMTD Digital Inc. (“AMTD Digital” or the “Company”) (NYSE: HKD), a comprehensive one-stop...
Egnyte Solidifies Investment in India with New Head of India
Sachin Shetty will manage operations in India to help accelerate growth for the team in the region MUMBAI, India &...
Valaris Reports Second Quarter 2022 Results
Continued Strong Operational Performance – 97% Revenue Efficiency in 2Q 2022 Four Floater Reactivation Projects Completed in Advance of Multi-Year...
Scrut Automation Launches ‘Risk Management’ for Cloud-Based Companies
Scrut Risk Management is designed to help customers manage their risks more effectively. The tool streamlines risk assessments by automating...
InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today...
Center Coast Brookfield MLP & Energy Infrastructure Fund Considering Strategic Options
NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Brookfield Public Securities Group (“PSG”), the investment adviser to Center Coast Brookfield...
V-SQUARE announces launch of V-Square MSCI Global Equity ESG Materiality and Carbon Transition Indexed Strategy for Australian Asset Owners
CHICAGO--(BUSINESS WIRE)--#Australia--Chicago based V-Square Quantitative Management LLC (V-Square), a global asset management firm with sustainability at its core, announced today...
Sinclair Announces Agreements with Korean Broadcasters to Further NextGen Broadcasting
HUNT VALLEY, Md.--(BUSINESS WIRE)--Sinclair Broadcast Group, Inc. (Nasdaq: SBGI), today announced that the company has entered into agreements with two...
CF Industries Holdings, Inc. Reports First Half 2022 Net Earnings of $2.05 Billion, Adjusted EBITDA of $3.60 Billion
Strong Operational Performance and Wide Energy Spreads Drive Record Results DEERFIELD, Ill.--(BUSINESS WIRE)--CF Industries Holdings, Inc. (NYSE: CF), a leading...
Navidea Biopharmaceuticals Announces Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer in Australia
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision...
Fabrinet to Announce Fourth Quarter and Fiscal-Year 2022 Financial Results on August 15, 2022
BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to...
GC Biopharma Reports Q2 2022 Results
YONGIN, South Korea--(BUSINESS WIRE)--GC Biopharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced...
